Live Breaking News & Updates on Y Mabs Clinical Trials

Stay updated with breaking news from Y mabs clinical trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Y-mAbs Therapeutics, Inc. (YMAB) Investor Alert: Robbins

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all. ....

San Diego , United States , Aaron Dumas , Y Mabs Therapeutic Inc , Y Mabs Therapeutics Inc , Advisory Committee Meeting , Securities Exchange , Memorial Sloan Kettering Cancer Center , Y Mabs Therapeutics , Securities Exchange Act , Case About , Lead Drug , Biologics License Application , Central German Childhood Cancer Registry , Briefing Document , Committee Meeting , Y Mabs Therapeutic , Robbins Llp , Y Mabs Clinical Trials , Y Mabs Shareholders , Y Mabs Stock Drop , Lass Action ,